Stocks · Health care · Pharmaceutical Preparations

MBX Biosciences, Inc.

MBX Clue Score38
United States Fiscal year ends December CIK 0001776111 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Salomon Azoulay
4 Nov 2026
Chief Medical Officer
Sell
373
$53.96
$20.13K
Salomon Azoulay
4 Aug 2026
Chief Medical Officer
Sell
370
$65.77
$24.33K
P. Kent Hawryluk
6 May 2026
President & CEO
Sell
607
$29.54
$17.93K
Salomon Azoulay
6 May 2026
Chief Medical Officer
Sell
231
$29.54
$6.82K

What was left out

Form 4 filings counted 24
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 274,959
History held since 13 Sep 2024